Adaptimmune Therapeutics plc

Q1 2016 13F Holders

Symbol
ADAP
CUSIP
00653A107
Type
Equity
Class
SPONDS ADR
Num filings
49
Total reported value, excl. options
$260 M
Manager Report Date Value ($000) Shares Option Type